OpenURL Connection Search

Select item for more details and to access through your institution.

Anti-tumour activity of tivozanib, a pan-inhibitor of VEGF receptors, in therapy-resistant ovarian carcinoma cells.
Published in:
Scientific Reports, 2017, p. 45954, doi. 10.1038/srep45954
By:
- Momeny, Majid;
- Sabourinejad, Zahra;
- Zarrinrad, Ghazaleh;
- Moghaddaskho, Farima;
- Eyvani, Haniyeh;
- Yousefi, Hassan;
- Mirshahvaladi, Shahab;
- Poursani, Ensieh M.;
- Barghi, Farinaz;
- Poursheikhani, Arash;
- Dardaei, Leila;
- Bashash, Davood;
- Ghazi-Khansari, Mahmoud;
- Tavangar, Seyyed M.;
- Dehpour, Ahmad R.;
- Yaghmaie, Marjan;
- Alimoghaddam, Kamran;
- Ghavamzadeh, Ardeshir;
- Ghaffari, Seyed H.
Publication type:
Article
Blockade of vascular endothelial growth factor receptors by tivozanib has potential anti-tumour effects on human glioblastoma cells.
Published in:
Scientific Reports, 2017, p. 44075, doi. 10.1038/srep44075
By:
- Momeny, Majid;
- Moghaddaskho, Farima;
- Gortany, Narges K.;
- Yousefi, Hassan;
- Sabourinejad, Zahra;
- Zarrinrad, Ghazaleh;
- Mirshahvaladi, Shahab;
- Eyvani, Haniyeh;
- Barghi, Farinaz;
- Ahmadinia, Leila;
- Ghazi-Khansari, Mahmoud;
- Dehpour, Ahmad R.;
- Amanpour, Saeid;
- Tavangar, Seyyed M.;
- Dardaei, Leila;
- Emami, Amir H.;
- Alimoghaddam, Kamran;
- Ghavamzadeh, Ardeshir;
- Ghaffari, Seyed H.
Publication type:
Article
The Deficiency of Tumor Suppressor <i>Prep1</i> Accelerates the Onset of <i>Meis1- Hoxa9</i> Leukemogenesis.
Published in:
PLoS ONE, 2014, v. 9, n. 5, p. 1, doi. 10.1371/journal.pone.0096711
By:
- Dardaei, Leila;
- Modica, Livia;
- Iotti, Giorgio;
- Blasi, Francesco
Publication type:
Article
A tale of TALE, PREP1, PBX1, and MEIS1: Interconnections and competition in cancer.
Published in:
BioEssays, 2017, v. 39, n. 5, p. n/a, doi. 10.1002/bies.201600245
By:
- Blasi, Francesco;
- Bruckmann, Chiara;
- Penkov, Dmitry;
- Dardaei, Leila
Publication type:
Article

Found: 4

Anti-tumour activity of tivozanib, a pan-inhibitor of VEGF receptors, in therapy-resistant ovarian carcinoma cells.

Blockade of vascular endothelial growth factor receptors by tivozanib has potential anti-tumour effects on human glioblastoma cells.

The Deficiency of Tumor Suppressor <i>Prep1</i> Accelerates the Onset of <i>Meis1- Hoxa9</i> Leukemogenesis.

A tale of TALE, PREP1, PBX1, and MEIS1: Interconnections and competition in cancer.